Functional Genomics: Arrayed CRISPR KO Screens

Authors:
Davide Gianni and Leire Escudero-Ibarz
In:
Source: Exp Opin Drug Discov
Publication Date: (2022)
Issue: 9: 127-136
Research Area:
Drug Discovery
Platform:
4D-Nucleofector® X-Unit
384-well HT Nucleofector® System
Experiment

The article is a book chapter and review of the current methods for drug discovery screenings and functional genomics.  The article shows the relevance of advanced biological models and the reviews current CRISP reagent delivery system. A focus is also the non viral technologies like Nucleofection and the option to run screens in the Lonza HTN 384 Nucleofector system

Abstract

Functional genomics is the discipline in molecular and cellular biology field that studies how genes and pathways contribute to a particular disease phenotype. Functional genomic screens are key in target discovery and hold the promise to enable the identification of drug targets with improved clinical attrition rate. The long-term success of target discovery and validation is currently based on four key pillar areas that will be reviewed in this chapter, including: (i) the creation and implementation of successful array screening modalities to perturb individual gene and protein functions in disease relevant models, (ii) the use of translatable and physiologically relevant models that mimic a particular disease phenotype and can be adapted to the screening throughput, (iii) the integration of complex assay readouts to interpret the biological outputs of cellular models upon perturbation, and (iv) the establishment of bioinformatic pipelines to enable quantitative analysis of phenotypic readouts resulting from genetic and
non-genetic perturbations.